The Clinical Guidelines Program is a longstanding, collaborative effort of the New York State Department of Health (NYSDOH) AIDS Institute (AI), Office of the Medical Director (OMD), and the Johns Hopkins University (JHU) School of Medicine, Division of Infectious Diseases.
Mission: To develop and disseminate practical, evidence-based clinical guidelines that promote quality medical care for people in New York who are living with and/or are at risk of acquiring HIV, HCV, STIs and substance use.
Expert committees: AIDS Institute clinical guidelines are developed by committees of expert New York State clinicians. Committee members collaborate to survey and evaluate peer-reviewed literature, write and assess clinical recommendations, and update existing guidelines or create new guidelines as necessary to ensure that recommendations reflect current best practices. All new and revised guidelines undergo peer and consumer review.
Evidence-based recommendations: Committee members apply their expertise and experience in evaluating factors that determine treatment decisions, including potential benefits and outcomes, risks, and burdens to the patient; patient views, values, and preferences; feasibility and tolerability; and the quality of evidence supporting a treatment recommendation. All recommendations are assigned ratings based on the strength and quality of the supporting evidence.
Audience: AIDS Institute clinical care guidelines are produced and disseminated to clinicians in New York who provide prevention services and medical care to people who are living with or at risk of acquiring HIV, HCV, STIs and substance use.
Stay Up-To-Date with the Clinical Guidelines Program: Subscribe to Topics, Trends & Updates to receive an email announcement when new guidelines or updates to guidelines are published, along with highlights from hot topics and events, and trends in guideline use. Subscribe now
Let Us Know What You Think: Complete our brief survey to give feedback on the guidelines and the website. Complete the survey now
- Topics, Trends & Updates (6/10/21)
- Updated: Laboratory Monitoring for Adverse Effects of ART (6/8/21)
- Updated: Use of Dolutegravir in Individuals of Childbearing Capacity (6/3/21)
- Updated: Prevention and Management of Hepatitis A Virus in Adults With HIV (5/21/21)
- Medscape Commentary: A Framework for Comprehensive HIV Primary Care (5/19/21)
- What We're Reading: Weight Gain Associated With TAF (5/6/21)
- Topics, Trends & Updates (5/6/21)
- Updated Guideline: Management of IRIS (4/28/21)
- NYC Health: FAQ About COVID-19 for Health Care Providers (3/24/21)
- NYCDOHMH: Dear Colleague COVID-19 Updates, Building Confidence in COVID-19 Vaccines and Vaccination (3/2/21)
- DHHS Interim Guidance for COVID-19 and Persons with HIV (3/1/21)
- CDC: COVID-19 and HIV (3/1/21)
- Medical Care Criteria Committee Advocates COVID-19 Vaccine Priority Status for People With HIV (1/12/21)
- Guidance: Opioid Use Disorder Treatment During COVID-19 (1/4/21)
- Guidance: Strategies for STI Screening and Treatment During COVID-19 (11/5/2020)
- Guidance: Rapid ART Initiation During COVID-19 (8/26/20)
- HHS: Updates to the Adult and Adolescent Opportunistic Infections Guidelines (6/15/21)
- CEI Newsletter (6/15/21)
- NYC Health: Free CME on Latent Tuberculosis Infection (6/9/21)
- NYS Medicaid Update: May 2021 (6/9/21)
- Syracuse University Aging Studies Institute: HIV+ Aging and Long-Term Survivors 2021 Survey (6/9/21)
- HHS: Updates to the Antiretroviral Agents in Adults and Adolescents Living with HIV Guidelines Released (6/3/21)
- COVID-19 Vaccine Updates: Johnson & Johnson/Janssen and People Vaccinated Outside the US (5/22/21)
- NYCDOHMH: COVID-19 Vaccine for Adolescents and Co-administration (5/19/21)
- NYCDOHMH: COVID-19 Vaccine Appointment Scheduling Resources and Information (4/13/21)
- NYCDOHMH: Dear Colleague COVID-19 Updates, COVID-19 Monoclonal Antibody Treatment in the Outpatient Setting (3/31/21)
- Governor Cuomo Announces Updated NYS Vaccine Eligibility (3/30/21)
- NYSDOH Vaccine Tracker--Updated Daily (3/30/21)